Sfoglia per AUTORE
CILLONI D
Collezione AOU San Luigi di Orbassano

  

Items : 32

2025
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Marconi G; Petracci E; Valli I; Volpi R; Zamagni F; Mattei A; Ottaviani E; Bochicchio MT; Bocchia M; Todisco E; Cilloni D; Rigolin GM; Giannini MB; Bernardi M; Romani C; Fracchiolla N; Olivieri A; Albano F; Lunghi M; Cambò B; Candoni A; Scappini B; Chiusolo P; Audisio E; Martelli MP; Martinelli G; Mulè A; Papayannidis C; Azzali I; et alii...

Comprehensive Molecular Profiling of NPM1-Mutated Acute Myeloid Leukemia Using RNAseq Approach. in International journal of molecular sciences / Int J Mol Sci. 2024 Mar 24;25(7):3631. doi: 10.3390/ijms25073631.
2024
AOU San Luigi di Orbassano

Petiti J; Pignochino Y; Schiavon A; Giugliano E; Berrino E; Giordano G; Itri F; Dragani M; Cilloni D; Lo Iacono M;

Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy. in Cancer / Cancer. 2024 Apr 15;130(8):1270-1280. doi: 10.1002/cncr.35156. Epub 2023 Dec 28.
2024
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Breccia M; Cavo M; Bonifacio M; Vianelli N; Trawinska MM; Cuneo A; Cilloni D; Semenzato G; Lemoli RM; Pane F; Krampera M; Cattaneo D; Isidori A; Duminuco A; Venturi M; Scaffidi L; Pugliese N; Martino B; Bocchia M; Crugnola M; Bosi C; Beggiato E; Miglino M; Branzanti F; Binotto G; Cavazzini F; Caocci G; Tieghi A; Auteri G; et alii...

Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib. in Blood cancer journal / Blood Cancer J. 2023 May 3;13(1):65. doi: 10.1038/s41408-023-00834-6.
2023
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Semenzato GC; Cuneo A; Krampera M; Lemoli RM; Bartoletti D; Cattaneo D; Santoni E; D'Addio A; Ceglie S; Rindone G; Romagnoli AD; Crugnola M; Mazzoni C; Bocchia M; Miglino M; Mendicino F; Tatarelli C; Beggiato E; Cilloni D; Cavazzini F; Binotto G; Caocci G; Polverelli N; Iurlo A; Tieghi A; Tiribelli M; Bosi C; Rossi E; Trawinska MM; et alii...

Detection of SF3B1 p.Lys700Glu Mutation by PNA-PCR Clamping in Myelodysplastic Syndromes and Myeloproliferative Neoplasms. in Journal of clinical medicine / J Clin Med. 2022 Feb 25;11(5):1267. doi: 10.3390/jcm11051267.
2022
AOU San Luigi di Orbassano

Petiti J; Itri F; Signorino E; Frolli A; Fava C; Armenio M; Marini S; Giugliano E; Lo Iacono M; Saglio G; Cilloni D;

Deferasirox in the management of iron overload in patients with myelofibrosis treated with ruxolitinib: The multicentre retrospective RUX-IOL study. in British journal of haematology / Br J Haematol. 2022 Apr;197(2):190-200. doi: 10.1111/bjh.18057. Epub 2022 Feb 8.
2022
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Palandri F; Latagliata R; Palumbo GA; Bucelli C; Gambacorti-Passerini C; Breccia M; Biale L; Scaffidi L; Renso R; Auteri G; Cattaneo D; Trawinska MM; Porrini R; Markovic U; Pugliese N; Caocci G; Crisà E; Tiribelli M; Cilloni D; Caramella M; Abruzzese E; Bonifacio M; Bergamaschi M; Polverelli N; Elli EM; Di Veroli A; Bartoletti D; Iurlo A; Carmosino I; et alii...

Droplet Digital PCR for BCR-ABL1 Monitoring in Diagnostic Routine: Ready to Start? in Cancers / Cancers (Basel). 2021 Oct 30;13(21):5470. doi: 10.3390/cancers13215470.
2021
AOU San Luigi di Orbassano

Bochicchio MT; Petiti J; Berchialla P; Izzo B; Giugliano E; Ottaviani E; Errichiello S; Rege-Cambrin G; Venturi C; Luciano L; Daraio F; Calistri D; Rosti G; Saglio G; Martinelli G; Pane F; Cilloni D; Gottardi EM; Fava C;

SARS-CoV-2 in Myelodysplastic Syndromes: A Snapshot From Early Italian Experience. in HemaSphere / Hemasphere. 2020 Sep 23;4(5):e483. doi: 10.1097/HS9.0000000000000483. eCollection 2020 Oct.
2020
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Tafuri A; Selleri C; Sciumé M; Secchi R; Sarlo C; Rivellini F; Poloni A; Riva M; Pelizzari A; Pilo F; Oliva E; Palumbo GA; Musto P; Niscola P; Messa E; Molteni A; Latagliata R; Mancini S; Gumenyuk S; Frattini F; Guaragna G; Gaidano V; Giai V; Finelli C; Filì C; Fianchi L; Ferrara IL; Fenu S; Di Veroli A; et alii...

Standardization of BCR-ABL1 p210 Monitoring: From Nested to Digital PCR. in Cancers / Cancers (Basel). 2020 Nov 6;12(11):3287. doi: 10.3390/cancers12113287.
2020
AOU San Luigi di Orbassano

Jovanovski A; Petiti J; Giugliano E; Gottardi EM; Saglio G; Cilloni D; Fava C;

2020
AOU San Luigi di Orbassano

Petiti J; Lo Iacono M; Dragani M; Pironi L; Fantino C; Rapanotti MC; Quarantelli F; Izzo B; Divona M; Rege-Cambrin G; Saglio G; Gottardi EM; Cilloni D; Fava C;

Highly Sensitive Detection of IDH2 Mutations in Acute Myeloid Leukemia. in Journal of clinical medicine / J Clin Med. 2020 Jan 19;9(1):271. doi: 10.3390/jcm9010271.
2020
AOU San Luigi di Orbassano

Petiti J; Rosso V; Croce E; Franceschi V; Andreani G; Dragani M; De Gobbi M; Lunghi M; Saglio G; Fava C; Lo Iacono M; Cilloni D;

Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing-Remitting Multiple Sclerosis Patients. in Neurology and therapy / Neurol Ther. 2020 Dec;9(2):197-203. doi: 10.1007/s40120-020-00200-9. Epub 2020 Jun 16.
2020
AOU San Luigi di Orbassano

Bertolotto A; Martire S; Mirabile L; Capobianco M; De Gobbi M; Cilloni D;

Clone wars: co-occurrence of IDH2 R140Q and R172K in myelodysplastic syndromes. in Annals of hematology / Ann Hematol. 2020 Apr;99(4):891-893. doi: 10.1007/s00277-020-03913-x. Epub 2020 Feb 4.
2020
AOU San Luigi di Orbassano

Rosso V; Petiti J; Dragani M; Andreani G; Croce E; Lo Iacono M; Saglio G; Fava C; Cilloni D;

Two conserved glycine residues in mammalian and Dictyostelium Rictor are required for mTORC2 activity and integrity. in Journal of cell science / J Cell Sci. 2019 Nov 14;132(22):jcs236505. doi: 10.1242/jcs.236505.
2019
AOU San Luigi di Orbassano

Pergolizzi B; Panuzzo C; Ali MS; Lo Iacono M; Levra Levron C; Ponzone L; Prelli M; Cilloni D; Calautti E; Bozzaro S; Bracco E;

Rhino-Orbital-Cerebral Mucormycosis after Allogeneic Hematopoietic Stem Cell Transplantation and Isavuconazole Therapeutic Drug Monitoring during Intestinal Graft versus Host Disease. in Mediterranean journal of hematology and infectious diseases / Mediterr J Hematol Infect Dis. 2019 Nov 1;11(1):e2019061. doi: 10.4084/MJHID.2019.061. eCollection 2
2019
ASL Città di Torino
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Cilloni D; Guerrasio A; Barbui AM; D'Avolio A; De Gobbi M; Morotti A; Monticone V; Cavallo G; Dragani M; Gned D; Andreani G; Fadda G;

The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib. in British journal of haematology / Br J Haematol. 2018 Sep;182(5):701-704. doi: 10.1111/bjh.15450. Epub 2018 Jul 9.
2018
ASL Asti
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Ferrero D; Boccadoro M; Mezzabotta M; Marchetti M; Lanzarone G; Cerrano M; Frairia C; Pugliese N; Beggiato E; Martinelli V; Palumbo GA; Elli EM; Cilloni D; Crisà E;

Clinical significance of TFR2 and EPOR expression in bone marrow cells in myelodysplastic syndromes. in British journal of haematology / Br J Haematol. 2017 Feb;176(3):491-495. doi: 10.1111/bjh.13968. Epub 2016 Feb 23.
2017
AOU San Luigi di Orbassano

Di Savino A; Gaidano V; Palmieri A; Crasto F; Volpengo A; Lorenzatti R; Scaravaglio P; Manello A; Nicoli P; Gottardi E; Saglio G; Cilloni D; De Gobbi M;

A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy. in British journal of haematology / Br J Haematol. 2013 Jun;161(5):688-694. doi: 10.1111/bjh.12332. Epub 2013 Apr 10.
2013
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Tollo SD; Finazzi MC; Barosi G; Sivera P; Cilloni D; Musolino C; Fioritoni G; Olimpieri OM; Pogliani EM; Specchia G; Nobile F; Ruggeri M; Martinelli V; Vannucchi AM; Finazzi G; Demuth T; Barbui T; Rambaldi A;

Emerging targets for hematological malignancies. in Current opinion in drug discovery & development / Curr Opin Drug Discov Devel. 2010 Sep;13(5):548-58.
2010
AOU San Luigi di Orbassano

Cilloni D; Frassoni F; Saglio G;

Emerging drugs for chronic myeloid leukemia. in Expert opinion on emerging drugs / Expert Opin Emerg Drugs. 2010 Jun;15(2):175-84. doi: 10.1517/14728211003621220.
2010
AOU San Luigi di Orbassano

Cilloni D; Messa E; Rotolo A; Saglio G;

2010
AOU San Luigi di Orbassano

Messa E; Carturan S; Maffè C; Pautasso M; Bracco E; Roetto A; Messa F; Arruga F; Defilippi I; Rosso V; Zanone C; Rotolo A; Greco E; Pellegrino RM; Alberti D; Saglio G; Cilloni D;

HHV8-positive, HIV-negative multicentric Castleman's disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma. in International journal of hematology / Int J Hematol. 2009 Oct;90(3):392-396. doi: 10.1007/s12185-009-0418-y. Epub 2009 Sep 12.
2009
ASL Città di Torino
AOU San Luigi di Orbassano

Saglio G; Cilloni D; Morotti A; Allice T; Mete F; Familiari U; Bosa M; Nicoli P; Guerrasio A;

Imatinib resistance in CML. in Cancer letters / Cancer Lett. 2009 Feb 8;274(1):1-9. doi: 10.1016/j.canlet.2008.06.003. Epub 2008 Jul 23.
2009
AOU San Luigi di Orbassano

Volpe G; Panuzzo C; Ulisciani S; Cilloni D;

2008
AOU San Luigi di Orbassano

Cilloni D; Messa F; Arruga F; Defilippi I; Gottardi E; Fava M; Carturan S; Catalano R; Bracco E; Messa E; Nicoli P; Diverio D; Sanz MA; Martinelli G; Lo-Coco F; Saglio G;

Molecular monitoring in patients with chronic myelogenous leukemia. in Current hematologic malignancy reports / Curr Hematol Malig Rep. 2008 Apr;3(2):65-71. doi: 10.1007/s11899-008-0011-0.
2008
AOU San Luigi di Orbassano

Saglio G; Ulisciani S; Fava M; Gottardi E; Cilloni D;

A young man with persistent eosinophilia. in Internal and emergency medicine / Intern Emerg Med. 2007 Jun;2(2):107-12. doi: 10.1007/s11739-007-0030-1.
2007
AOU San Luigi di Orbassano

Messa E; Cilloni D; Saglio G;

Genetic abnormalities as targets for molecular therapies in myelodysplastic syndromes. in Annals of the New York Academy of Sciences / Ann N Y Acad Sci. 2006 Nov;1089:411-23. doi: 10.1196/annals.1386.030.
2006
AOU San Luigi di Orbassano

Cilloni D; Messa E; Messa F; Carturan S; Defilippi I; Arruga F; Rosso V; Catalano R; Bracco E; Nicoli P; Saglio G;

WT1 overexpression: a clinically useful marker in acute and chronic myeloid leukemias. in Hematology (Amsterdam, Netherlands) / Hematology. 2005;10 Suppl 1:76-8. doi: 10.1080/10245330512331390005.
2005
AOU San Luigi di Orbassano

Saglio G; Carturan S; Grillo S; Capella S; Arruga F; Defilippi I; Rosso V; Rauco M; Marina Liberati A; Cilloni D;

Myelodysplastic syndromes. in Annals of the New York Academy of Sciences / Ann N Y Acad Sci. 2004 Dec;1028:400-8. doi: 10.1196/annals.1322.048.
2004
AOU San Luigi di Orbassano

Cilloni D; Messa F; Carturan S; Arruga F; Defilippi I; Messa E; Gottardi E; Saglio G;

Abl: the prototype of oncogenic fusion proteins. in Cellular and molecular life sciences : CMLS / Cell Mol Life Sci. 2004 Dec;61(23):2897-911. doi: 10.1007/s00018-004-4271-0.
2004
AOU San Luigi di Orbassano

Saglio G; Cilloni D;

Rational approaches to the design of therapeutics targeting molecular markers: the case of chronic myelogenous leukemia. in Annals of the New York Academy of Sciences / Ann N Y Acad Sci. 2004 Dec;1028:423-31. doi: 10.1196/annals.1322.050.
2004
AOU San Luigi di Orbassano

Saglio G; Morotti A; Mattioli G; Messa E; Giugliano E; Volpe G; Rege-Cambrin G; Cilloni D;

From genes to therapy: the case of Philadelphia chromosome-positive leukemias. in Annals of the New York Academy of Sciences / Ann N Y Acad Sci. 2002 Jun;963:306-12. doi: 10.1111/j.1749-6632.2002.tb04122.x.
2002
AOU San Luigi di Orbassano

Cilloni D; Guerrasio A; Giugliano E; Scaravaglio P; Volpe G; Rege-Cambrin G; Saglio G;